CLINICAL RESEARCH
Herring oil intake results in increased levels of omega-3 fatty acids in erythrocytes in an urban population in the Czech Republic
 
More details
Hide details
 
Submission date: 2017-12-07
 
 
Final revision date: 2018-01-08
 
 
Acceptance date: 2018-01-08
 
 
Publication date: 2018-02-05
 
 
Arch Med Sci Civil Dis 2018;3(1):3-9
 
KEYWORDS
TOPICS
ABSTRACT
Introduction: The prevalence of cardiovascular diseases is relatively high in Central European countries, which may be caused by unhealthy dietary habits and cigarette smoking. The traditional Czech diet is low in seafood – a food reported to offer some reduction of risk for myocardial infarct and stroke. The European Health Authority recommends regular intake of fish or food supplements providing at least 250 mg of the omega-3 fatty acids eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) daily.
Material and methods: The present study included 100 subjects from Prague not eating fish. They were given herring fish oil capsules providing aproximately the recommended dose of EPA + DHA for 6 months. Omega-3 and other fatty acids were analysed from red blood cells (RBC) before and after study completion. Study parameters were omega-3 index, EPA + DHA, and the atherogenic index comprising saturated fatty acids divided by unsaturated fatty acids.
Results: Mean omega-3 index at study entry was 5.1% (p < 0.01) increasing to 10.7%, while mean EPA + DHA increased by 112% (p < 0.01).
Conclusions: Capsules of herring oil containing 250 mg EPA + DHA daily increased RBC content of omega-3 fatty acids, increasing the omega-3 index to low or intermediate risk values in 83% of the subjects studied. In populations with low access to or no tradition of eating fish, herring oil capsules providing the EU recommended dose of omega-3 fatty acids might reduce cardiovascular risk as indicated by the surrogate parameter omega-3 index.
REFERENCES (26)
1.
Mackenbach JP. Convergence and divergence of life expectancy in Europe: a centennial view. Eur J Epidemiol 2013; 28: 229-40.
 
2.
Nestel P, Clifton P, Colquhoun D, et al. Indications for omega-3 long chain polyunsaturated fatty acid in the prevention and treatment of cardiovascular disease. Heart Lung Circulation 2015; 24: 769-79.
 
3.
Weylandt KH, Serini S, Chen YQ, et al. Omega-3 polyunsaturated fatty acids: the way forward in times of mixed evidence. BioMed Res Int 2015; 2015: 143109.
 
4.
Colussi G, Catena C, Sechi LA. Omega-3 polyunsaturated fatty acids effects on the cardiometabolic syndrome and their role in cardiovascular disease prevention: an update from the recent literature. Recent Adv Cardiovasc Drug Discov 2014; 9: 78-96.
 
5.
Kromhout D, de Goede J. Update on cardiometabolic health effects of omega-3 fatty acids. Curr Opin Lipidol 2014; 25: 85-90.
 
6.
Mozaffarian D, Lemaitre RN, King IB, et al. Plasma phospholipid long chain omega-3 fatty acids and total and cause-specific mortality in older adults. Ann Intern Med 2013; 158: 515-25.
 
7.
Calder PC, Yaqoob P. Marine omega-3 fatty acids and coronary heart disease. Curr Opinion Cardiol 2012; 27: 412-9.
 
8.
Halim SA, Newby LK. Review: omega-3 fatty acid supplements provide no protective benefit in cardiovascular disease. Ann Intern Med 2012; 157: JC2-3.
 
9.
Kwak SM, Myung S, Lee YJ, et al. Efficacy of omega-3 fatty acid supplements (eicosapentaenoic acid and docosahexaenoic acid) in the secondary prevention of cardiovascular disease: a meta-analysis of randomized, double-blind, placebo-controlled trials. Arch Intern Med 2012; 172: 686-94.
 
10.
Alexander DD, Miller PE, Van Van Elswyk ME, Kuratko CN, Bylsma LC. A meta-analysis of randomized controlled trials and prospective cohort studies of eicosapentaenoic and docosahexaenoic long-chain omega-3 fatty acids and coronary heart disease risk. May Clin Proc 2017; 92: 15-29.
 
11.
von Schacky C. Use of red blood cell fatty-acid profiles as biomarkers in cardiac disease. Biomarkers Med 2009; 3: 25-32.
 
12.
Harris WS, Sands SA, Windsor SL, et al. Omega-3 fatty acids in cardiac biopsies from heart transplantation patients: correlation with erythrocytes and response to supplementation. Circulation 2004; 110: 1645-9.
 
13.
von Schacky C. Omega-3 fatty acids in cardiovascular disease. Prostaglandins Leukotr Essent Fatty Acids 2015; 92: 41-7.
 
14.
Johnston DT, Deuster PA, Harris WS, et al. Red blood cell omega-3 fatty acid levels and neurocognitive performance in deployed U.S. Service members. Nutr Neurosci 2013; 16: 30-8.
 
15.
Sarter B, Kelsey KS, Schwartz TA, et al. Blood docosahexaenoic acid and eicosapentaenoic acid in vegans: associations with age and gender and effects of an algal-derived omega-3 fatty acid supplement. Clin Nutr 2015; 34: 212-8.
 
16.
Nagasaka R, Gagnon C, Swist E, et al. EPA and DHA status of South Asian and white Canadians living in the National Capital Region of Canada. Lipidy 2014; 49: 1057-69.
 
17.
Cao J, Schwichterberg KA, Hanson NQ, Tsai MY. Incorporation and clearance of omega-3 fatty acids in erythrocyte membranes and plasma phospholipids. Clin Chem 2006; 52: 2265-72.
 
18.
EFSA. Dietary references values for fats. EFSA J 2010; 8: 1461.
 
19.
Calder PC, Yaqoob P. Omega-3 (n-3) fatty acids, cardiovascular disease and stability of atherosclerotic plaques. Cell Mol Biol 2010; 56: 28-37.
 
20.
Folch J, Lees M, Sloane-Stanley CM. A simple method for the isolation and purification of total lipides from animal tissues. J Biol Chem 1957; 226: 497-509.
 
21.
Carlson LA. Extraction of lipids from human whole serum and lipoproteins and from rat liver tissue with methylene chloride-methanol: a comparison with extraction with chloroform-methanol. Clin Chim Acta 1985; 149: 89-93.
 
22.
Harris WS, Schmitt TL. Unexpected similarity in RBC DHA and AA levels between bottlenose dolphins and humans. Prostaglandins Leukot Essent Fatty Acids 2014; 90: 55-9.
 
23.
Ulbright TLV, Southgate DAT. Coronary heart disease: seven dietary factors. Lancet 1991; 338: 985-92.
 
24.
Fielding BA. Omega-3 index as a prognosis tool in cardiovascular disease. Curr Opin Clin Nutr Metabol Care 2017; 20: 360-5.
 
25.
Kleiner AC, Cladis DP, Santerre CR. A comparison of actual versus stated label amounts of EPA and DHA in commercial omega-3 dietary supplements in the United States. J Sci Food Agric 2014; 95: 1260-7.
 
26.
ICES (2017) Herring (Clupea harengus) in subareas 1, 2, and 5, and in divisions 4.a and 14.a, Norwegian spring-spawning herring (the Northeast Atlantic and the Arctic Ocean). ICES Advice on fishing opportunities, catch, and effort Northeast Atlantic and Arctic Ocean. Version 2: 30 October 2017. ICES, Copenhagen.
 
ISSN:2451-0637
Journals System - logo
Scroll to top